{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:17:51Z","timestamp":1785352671808,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinre.2023.102155","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:23:08Z","timestamp":1686262988000},"page":"102155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression"],"prefix":"10.1016","volume":"47","author":[{"given":"Anuraag","family":"Jena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardhu B","family":"Neelam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshavardhan","family":"Telaprolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Kiran","family":"Mangipudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-3409","authenticated-orcid":false,"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5217\/ir.2020.00155","article-title":"Use of thiopurines in inflammatory bowel disease: an update","volume":"20","author":"Singh","year":"2022","journal-title":"Intest Res"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0002","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17512433.2021.1900729","article-title":"Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis","volume":"14","author":"Jena","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0003","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ibd\/izx081","article-title":"Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine","volume":"24","author":"Munnig-Schmidt","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.clinre.2023.102155_bib0004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mi.2013.73","article-title":"New targets for mucosal healing and therapy in inflammatory bowel diseases","volume":"7","author":"Neurath","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0006","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","article-title":"Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins","volume":"176","author":"Poppe","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.15403\/jgld-2765","article-title":"Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide","volume":"29","author":"Crouwel","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"issue":"7","key":"10.1016\/j.clinre.2023.102155_bib0008","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1634\/theoncologist.2014-0178","article-title":"6-thioguanine: a drug with unrealized potential for cancer therapy","volume":"19","author":"Munshi","year":"2014","journal-title":"Oncologist"},{"issue":"20","key":"10.1016\/j.clinre.2023.102155_bib0009","first-page":"5387","article-title":"6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells","volume":"54","author":"Morgan","year":"1994","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/toxics10040151","article-title":"Skrzypczak-Zieli\u0144ska M. Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease","volume":"10","author":"Zakerska-Banaszak","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.clinre.2023.102155_bib0011","article-title":"Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?","volume":"8","author":"Gargallo-Puyuelo","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinre.2023.102155_bib0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mimet.2016.07.017","article-title":"Microbial metabolism of thiopurines: A method to measure thioguanine nucleotides","volume":"128","author":"Movva","year":"2016","journal-title":"J Microbiol Methods"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212157","article-title":"Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review","volume":"14","author":"Toksvang","year":"2019","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.clinre.2023.102155_bib0014","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3748\/wjg.v22.i40.9012","article-title":"Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review","volume":"22","author":"Meijer","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2023.102155_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2023.102155_bib0016","series-title":"R A language and environment for statistical computing","year":"2022"},{"key":"10.1016\/j.clinre.2023.102155_bib0017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jrsm.1260","article-title":"Introduction, comparison, and validation of meta-essentials: a free and simple tool for metaanalysis","volume":"8","author":"Suurmond","year":"2017","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clinre.2023.102155_bib0018","series-title":"JBI Manual for Evidence Synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"issue":"3","key":"10.1016\/j.clinre.2023.102155_bib0019","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00054725-200108000-00001","article-title":"An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy","volume":"7","author":"Dubinsky","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"1-2","key":"10.1016\/j.clinre.2023.102155_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1445-5994.2003.00321.x","article-title":"6-thioguanine: a new old drug to procure remission in inflammatory bowel disease","volume":"33","author":"Cheung","year":"2003","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2036.2003.01683.x","article-title":"Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine\/mercaptopurine","volume":"18","author":"Bonaz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2036.2003.01440.x","article-title":"6-thioguanine\u2013efficacy and safety in chronic active Crohn's disease","volume":"17","author":"Herrlinger","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042737-200301000-00011","article-title":"6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment","volume":"15","author":"Derijks","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0024","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinsky","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.clinre.2023.102155_bib0026","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.2003.01590.x","article-title":"Remission maintenance by tioguanine in chronic active Crohn's disease","volume":"17","author":"Herrlinger","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.clinre.2023.102155_bib0027","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","article-title":"Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease","volume":"28","author":"Geller","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.clinre.2023.102155_bib0028","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/00365520510023369","article-title":"A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis","volume":"40","author":"Teml","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0029","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"issue":"35","key":"10.1016\/j.clinre.2023.102155_bib0030","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3748\/wjg.v11.i35.5540","article-title":"On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients","volume":"11","author":"de Boer","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clinre.2023.102155_bib0031","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"17-18","key":"10.1016\/j.clinre.2023.102155_bib0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-007-0841-0","article-title":"A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease","volume":"119","author":"Teml","year":"2007","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365520600825166","article-title":"Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease","volume":"42","author":"Qasim","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2007.10.013","article-title":"Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients","volume":"40","author":"de Boer","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.dld.2006.10.007","article-title":"Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?","volume":"39","author":"Gilissen","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.clinre.2023.102155_bib0036","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ibd.20492","article-title":"Further experience with the use of 6-thioguanine in patients with Crohn's disease","volume":"14","author":"Ansari","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.clinre.2023.102155_bib0037","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2008.07.314","article-title":"6-Thioguanine therapy in Crohn's disease\u2013observational data in Swedish patients","volume":"41","author":"Almer","year":"2009","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0038","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.dld.2010.07.004","article-title":"Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis","volume":"43","author":"van Asseldonk","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2011.07.009","article-title":"Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment","volume":"6","author":"van Asseldonk","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"12","key":"10.1016\/j.clinre.2023.102155_bib0040","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/MIB.0000000000000206","article-title":"Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study","volume":"20","author":"Pavlidis","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.clinre.2023.102155_bib0041","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1097\/MIB.0000000000000869","article-title":"The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease","volume":"22","author":"van Asseldonk","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0042","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/2050640616663438","article-title":"Thioguanine in inflammatory bowel disease: Long-term efficacy and safety. United","volume":"5","author":"Ward","year":"2017","journal-title":"European Gastroenterol J"},{"issue":"7","key":"10.1016\/j.clinre.2023.102155_bib0043","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/ibd\/izy047","article-title":"Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness","volume":"24","author":"Meijer","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0044","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/apt.15280","article-title":"Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies","volume":"50","author":"Simsek","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinre.2023.102155_bib0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/00365521.2019.1629006","article-title":"Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients","volume":"54","author":"van Asseldonk","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clinre.2023.102155_bib0046","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/apt.15730","article-title":"A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients","volume":"51","author":"Biemans","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0047","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12876-020-01441-6","article-title":"Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom","volume":"20","author":"Bayoumy","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0048","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/imj.15639","article-title":"Low-dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines","volume":"53","author":"Eqbal","year":"2023","journal-title":"Intern Med J"},{"key":"10.1016\/j.clinre.2023.102155_bib0049","first-page":"jjac044","article-title":"Favourable tolerability and drug survival of tioguanine versus methotrexate after failure of conventional thiopurines in Crohn's disease","author":"Savelkoul","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2023.102155_bib0050","first-page":"jjad013","article-title":"Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study","author":"Simsek","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.clinre.2023.102155_bib0051","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.49.6.874a","article-title":"Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine","volume":"49","author":"de Jong","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0052","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2036.2003.01652.x","article-title":"High variation of tioguanine absorption in patients with chronic active Crohn's disease","volume":"18","author":"Deibert","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0053","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.ftd.0000179839.71138.6d","article-title":"Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease","volume":"28","author":"Derijks","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0054","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1476-5381.2011.01265.x","article-title":"Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine","volume":"163","author":"Jharap","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.clinre.2023.102155_bib0055","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/imj.15057","article-title":"Tioguanine as an alternative immunomodulator in inflammatory bowel diseases","volume":"50","author":"Shir Ali","year":"2020","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0056","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15403\/jgld.2014.1121.274.tor","article-title":"Patient-Reported Experiences with a Relicensed Generic: Thioguanine for the Treatment of Inflammatory Bowel Diseases","volume":"27","author":"Simsek","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0057","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/17474124.2017.1294062","article-title":"Is there a role for thioguanine therapy in IBD in 2017 and beyond?","volume":"11","author":"Taylor","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0058","first-page":"950","article-title":"6-TG for IBD. simple, but safe?","volume":"98","author":"Tremaine","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0059","first-page":"232","article-title":"6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"38","author":"Walker","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.clinre.2023.102155_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ecco-jcc\/jjv189","article-title":"Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease","volume":"10","author":"van den Berg","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0061","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40264-021-01045-3","article-title":"IBDREAM registry. Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry","volume":"44","author":"Giraud","year":"2021","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.clinre.2023.102155_bib0062","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/bega.2002.0346","article-title":"Optimizing treatment with thioguanine derivatives in inflammatory bowel disease","volume":"17","author":"Louis","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102155_bib0063","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00054725-200311000-00010","article-title":"6TG: when less is more than you bargained for","volume":"9","author":"Mahadevan","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.clinre.2023.102155_bib0064","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1093\/ibd\/izy173","article-title":"6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease","volume":"24","author":"Mao","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.clinre.2023.102155_bib0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2004.01947.x","article-title":"Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease","volume":"19","author":"Herrlinger","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinre.2023.102155_bib0066","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/MPG.0000000000003621","article-title":"Kids with Crohn's, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands. Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series","volume":"75","author":"Bayoumy","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.clinre.2023.102155_bib0067","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjac183","article-title":"Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease","volume":"17","author":"Crouwel","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2023.102155_bib0068","first-page":"izac195","article-title":"Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series","author":"Crouwel","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2023.102155_bib0069","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2288-14-109","article-title":"Improving the error rates of the Begg and Mazumdar test for publication bias in fixed effects meta-analysis","volume":"14","author":"Gjerdevik","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102155_bib0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat Genet"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:27Z","timestamp":1761896067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740123000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2210740123000803"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102155","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102155"}}